While overall pediatric T-ALL patient survival was high in this cohort, we found that patients with the highest (top 20%) CHMP5 expression had poorer overall survival (Log-rank test, P = 0.017) compared to patients with the lowest (bottom 20%) CHMP5 expression in this cohort (Figure 5D). Here, CHMP5 is linked to acute lymphoblastic leukemia.